Moleculin Biotech, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Moleculin Biotech, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2017 to Q3 2024.
  • Moleculin Biotech, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $353K, a 28.4% decline year-over-year.
  • Moleculin Biotech, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $1.78M, a 12.8% decline year-over-year.
  • Moleculin Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.98M, a 12.8% decline from 2022.
  • Moleculin Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.28M, a 4.13% decline from 2021.
  • Moleculin Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.37M, a 41.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.78M $353K -$140K -28.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.92M $453K -$60K -11.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.98M $493K -$6K -1.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $1.98M $479K -$56K -10.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 $2.04M $493K -$206K -29.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $2.25M $513K -$1K -0.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $2.25M $499K -$28K -5.31% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $2.28M $535K -$23K -4.12% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 $2.3M $699K -$278K -28.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $2.58M $514K +$81K +18.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $2.5M $527K +$122K +30.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $2.37M $558K +$143K +34.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $2.23M $977K +$517K +112% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.71M $433K +$25K +6.13% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $1.69M $405K +$8K +2.02% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $1.68M $415K +$33K +8.64% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 $1.65M $460K -$29K -5.93% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1.68M $408K +$90K +28.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $1.59M $397K +$49K +14.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $1.54M $382K +$67K +21.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-24
Q3 2019 $1.47M $489K +$245K +100% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.23M $318K -$21K -6.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $1.25M $348K +$106K +43.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $1.14M $315K +$94K +42.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 $1.05M $244K -$22K -8.27% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.07M $339K +$229K +208% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-16
Q1 2018 $839K $242K +$132K +120% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 $707K $221K Oct 1, 2017 Dec 31, 2017 10-K 2019-02-21
Q3 2017 $266K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $110K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $110K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.